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Recent reports suggest that fibrin glue can be used to seal porous vascular grafts prior to insertion, 
but this ability has not been quantitatively compared to existing methods. We compared blood loss 
from and handling characteristics of grafts pretreated with either fibrin glue (FG) (T&eel), albumin 
autoclaving (AA), or blood preclotting (BP). Five 6-cm segments of 6-mm internal diameter grafts, 
both knitted and woven double velour Dacron were treated in each group (30 specimens). Human 
blood was forced through the BP group until clotted; AA segments were soaked in 25% human albumin 
and autoclaved for 10 min; FG segments were treated with a topical application of Tisseel (0.5 
ml/graft) followed by treatment with topical thrombin + CACl(0.5 ml/graft). Graft ends were sealed 
and attached to a transducer/syringe pump mechanism which pumped heparinized human blood into 
the graft at 100 mm Hg intraluminal pressure. All blood that leaked through the grafts over 2 min was 
collected and the amount was averaged for the five grafts in each group. Graft handling was character- 
ized as either pliable or stiff. Blood pretreatment caused 2 1 + 2 and 13 f  4 cc/2 min of leak in knitted 
and woven grafts, respectively. Albumin autoclaving resulted in 9 + 2 and 1 f  0.5 cc of leak (P < 0.0 1 
compared to blood), while fibrin glue produced 2 f  2 and 0.4 f  0.5 cc leaks (P < 0.01 compared to 
blood). Both blood and fibrin glue produced soft pliable grafts, while albumin pretreatment resulted in 
stiff grafts. We conclude that fibrin glue or albumin is superior to blood for pretreatment of woven 
grafts in limiting blood loss, but that fibrin glue is superior to either albumin or blood in knitted grafts. 
Fibrin glue imparts superior handling characteristics. o 1987 Academic PEP,, I~C. 
Primarily in Europe, fibrin glue has been 
used extensively since the early 1970s to pre- 
vent bleeding from suture lines and to pre- 
treat porous vascular grafts. Reports of its 
use are available as variable antecdoctal re- 
ports [ 1, 2, 31 but fibrin glue has heretofore 
never been compared quantitatively or quali- 
tatively to other methods of sealing porous 
vascular grafts. 
This study was designed to determine the 
degree of sealing achieved by fibrin glue and 
to compare this result to that achieved by the 
traditional methods of pretreatment, blood 
preclotting, and albumin autoclaving. The 
amount of blood loss through and handling 
characteristics of both woven and knitted 
’ To whom reprint requests should be addressed at 
Division of Cardiothoracic Surgery, University of Mary- 
land Hospital, 22 South Greene Street, Baltimore, MD 
21201. 
double velour vascular grafts were evaluated 
for these three methods of pretreatment to 
determine the best available. 
METHODS 
Six-centimeter lengths of both knitted and 
woven double velour 6-mm porous vascular 
grafts (Meadox) were obtained (30 total 6-cm 
specimens). Ten segments each (5 knitted, 5 
woven) were treated with blood preclotting, 
albumin autoclaving, or fibrin glue sealing. 
Blood preclotting was performed by forc- 
ing freshly obtained unheparinized blood 
through the vascular graft by using a cath- 
eter-tipped syringe while keeping the distal 
end sealed. Blood was continuously forced 
through the graft until clotting occurred; any 
intraluminal clot was squeezed out. 
Albumin autoclaving was performed on 
another 10 segments. Segments were soaked 
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TABLE 1 
Blood leak (cc) 
Knitted 
Blood (BP) 21*2 
Albumin (AA) 9 + 2* 
Fibrin glue (FG) 2 + 2* 
* P < 0.01 compared to blood. 
Woven 
13 +4 
1 f  0.5* 
0.4 f 0.5* 
in 25% human albumin and then autoclaved 
for 10 min. 
A further 10 segments were treated with 
fibrin glue (Tisseel, Immuno, Ltd, Arctic 
House, Rye Lane, Dunton Green, Nr Seven- 
oaks, Kent, England). Graft segments were 
first covered with 0.5 cc of Tisseel (human 
fibrin seal) and then covered with 0.5 cc of 
topical thrombin mixed with calcium chlo- 
ride. The fibrin glue-treated grafts were not 
allowed to dry. 
Distal graft ends were then sealed. Proxi- 
mal graft ends were tied around a 
Christmas-tree adaptor so that 5 cm of graft 
length was exposed. Heparinized blood was 
then forced into the graft at a pressure of 100 
mm Hg for a 2-min period. All blood leaking 
through the graft interstices was collected 
and measured. 
Mean graft leakage was calculated for the 
five grafts in each group. Results are dis- 
played in Table 1 as means + SD. Statistical 
significance was determined using one-way 
analysis of variance. 
Handling characteristics were assessed by 
manually squeezing and molding the graft 
segments. 
RESULTS 
The amount of blood leaking through ei- 
ther knitted or woven grafts is displayed in 
Table 1. Blood preclotting was ineffective in 
preventing blood loss through vascular 
grafts, particularly the knitted variety. Albu- 
min was an excellent agent for preventing 
blood loss through woven grafts, and while 
superior to blood, it still allowed for sizable 
leakage in knitted grafts. Fibrin glue pro- 
duced nearly complete sealing of both knit- 
ted and woven grafts and was superior to 
blood in both types of grafts. It was also supe- 
rior to albumin in pretreating knitted grafts. 
Handling characteristics of both blood- 
and fibrin glue-treated grafts were excellent, 
both methods resulting in supple, easily han- 
dled grafts. Occasionally, blood-treated grafts 
were characterized as “sticky” while fibrin 
glue grafts were described as “slimy.” Albu- 
min-pretreated grafts were stiff and hard to 
mold, even seeming to “crack” with hard 
bending. Pieces of “cooked” albumin would 
flake off during handling. 
DISCUSSION 
Although experience with fibrin glue in 
some form is now well reported both in the 
United States and in Europe [ l-71, this study 
is the first to compare its benefits quantita- 
tively and qualitatively in preventing blood 
loss through porous vascular grafts with 
other traditional agents. This comparison is 
useful both to expand the indications for fi- 
brin glue’s use and to justify its use when 
other agents might be available. 
While blood preclotting costs nothing, if 
significant blood loss occurs through the 
graft once in situ, the additional expenditure 
for blood replacement given the patient may 
quickly negate this cost advantage. When fi- 
brin glue’s use prevents or lessens the need 
for whole blood or packed cell replacement, 
then its small attendant risk of hepatitis 
transmission is nullified. 
Fibrin glue has the additional advantage 
over blood in that blood preclotting cannot 
be performed in heparinized patients, a con- 
dition which occurs frequently in operations 
upon patients with ischemic limbs who have 
been placed on heparin therapy preopera- 
tively. While the newer woven Dacron grafts 
have better preclotting ability and improved 
handling characteristics, many surgeons find 
distinct advantages in knitted grafts, which 
will continue to require preclotting for the 
immediate future. 
GUNDRY AND BEHRENDT: POROUS VASCULAR GRAFTS 
Albumin preclotting has the distinct dis- 
advantage of requiring a waiting period while 
the graft is cooked. Moreover, as is apparent 
to most people who have utilized this tech- 
nique, the resultant graft is stiff and difficult 
to handle. The propensity of an albumin 
crust to flake off into the lumen of the graft 
and cause distal embolization is also of con- 
cern. Prosthetic valve function in composite 
grafts may also be adversely affected by al- 
bumin crusting. 
SUMMARY 
At present, Tisseel, the form of fibrin glue 
utilized in this study, is not available in the 
United States. An equally effective method 
of making fibrin glue can be achieved by 
using cryoprecipitate in place of Tisseel. 
Cryoprecipitate is a rich source of fibrinogen, 
the active ingredient of Tisseel. In our gen- 
eral practice, a unit of cryoprecipitate is ob- 
tained thawed from the blood bank and 
placed in a 1 O-cc syringe. An ampoule of top- 
ical thrombin is similarly drawn up in a sec- 
ond syringe. Previously, we have mixed cal- 
cium chloride with the topical thrombin but 
we have eliminated it for the past 2 years and 
have noted no difference in effectiveness. 
The graft is covered with cryoprecipitate and 
rubbed in. This is followed by application of 
the topical thrombin which is similarly 
rubbed in. The graft should then be used 
soon after treatment; if drying occurs, leak 
rates rise. If grafts become dry, retreatment 
can be done in place. Indeed, if a leaky spot is 
noted on the grafts once in place, topical ap- 
plication of fibrin glue on the spot seals the 
leak. 
We conclude that fibrin glue or albumin is 
superior to blood preclotting for pretreat- 
ment of woven grafts in limiting blood loss, 
but that fibrin glue is superior to either albu- 
min or blood in pretreating knitted grafts. 
Fibrin glue imparts superior handling char- 
acteristics over those achieved with albumin. 
We currently recommend that vascular 
grafts be treated with fibrin glue as the agent 
of choice to prevent blood loss through the 
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